Randomized phase II trial of S‐1 plus cisplatin or docetaxel plus cisplatin with concurrent thoracic radiotherapy for inoperable stage III non‐small cell lung cancer

Cisplatin‐based chemoradiotherapy is considered standard treatment for unresectable locally advanced non‐small‐cell lung cancer (LA‐NSCLC). This study examined two regimens of chemotherapy in concurrent chemoradiation. Eligible patients with unresectable, radically irradible LA‐NSCLC were randomized...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Med
Main Authors: Shimokawa, Tsuneo, Yamada, Kazuhiko, Tanaka, Hiroshi, Kubota, Kaoru, Takiguchi, Yuichi, Kishi, Kazuma, Saito, Haruhiro, Hosomi, Yukio, Kato, Terufumi, Harada, Daijiro, Otani, Sakiko, Kasai, Takashi, Nakamura, Yoichi, Misumi, Toshihiro, Yamanaka, Takeharu, Okamoto, Hiroaki
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Clinical Cancer Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7877366/
https://ncbi.nlm.nih.gov/pubmed/33319495
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.3641
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados